IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Performance
Performance Report
Veeda Clinical Research IPO listing price is [●], issue price is [●], and currently trading at [●] as on [●]. Veeda Clinical Research IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Veeda Clinical Research IPO is a Book Building listing on BSE,NSE exchange. The company is based in Ahmedabad and caters to Pharmaceutical sector. Axis Bank , Clsa India , Iifl Securities , SBI Capital Markets are the merchant bankers of Veeda Clinical Research IPO. It is a MainBoard Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 31st January 2025.
Veeda Clinical Research IPO offer price is [●] and got listed at [●]. Read Veeda Clinical Research IPO details mentioned above.The IPO of Veeda Clinical Research Limited was listed on [●]. As of today, Veeda Clinical Research IPO is trading at [●], compared to the previous day’s close of [●]. Read the report above for detailed IPO performance.
The issue price of Veeda Clinical Research IPO was [●] per equity share.
Veeda Clinical Research IPO was listed at ₹ on the stock exchange on [●]. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of [●], the current market price of Veeda Clinical Research IPO is [●].
The 52-week high for Veeda Clinical Research IPO is [●], while the 52-week low is [●]. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Veeda Clinical Research IPO listed at [●] against the issue price of [●] per equity share, showing a listing day gain/loss of -1 (-100.00%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Veeda Clinical Research IPO stock moved from its listing price of [●] to the current price of ₹[●] per equity share, reflecting a change of 0.00% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Veeda Clinical Research IPO issue date of [●] and CMP of ₹[●], the estimated CAGR is approximately 0%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 2
Issue
Price :
[●]
Listing Price :
[●]
Previous Day Closing
[●]
Veeda Clinical Research IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Veeda Clinical Research Financial Review Page
Merchant Banker(s) of Veeda Clinical Research IPO: Axis Bank Limited , Clsa India Private Limited , Iifl Securities Limited , SBI Capital Markets Limited
Veeda Clinical Research IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Veeda Clinical Research IPO listed at a listing price of against the offer price of .
The current market price of Veeda Clinical Research is .
Why Us?
